Characterization of KIR + NKG2A + Eomes- NK-like CD8+ T cells and their decline with age in healthy individuals.


Journal

Cytometry. Part B, Clinical cytometry
ISSN: 1552-4957
Titre abrégé: Cytometry B Clin Cytom
Pays: United States
ID NLM: 101235690

Informations de publication

Date de publication:
07 2021
Historique:
revised: 03 07 2020
received: 03 04 2020
accepted: 21 07 2020
pubmed: 25 8 2020
medline: 8 1 2022
entrez: 25 8 2020
Statut: ppublish

Résumé

KIR+NKG2A + Eomes+ CD8+ T cells, which are preferentially found with a T We compare the distribution of the memory phenotypes and senescence-associated markers of two T-cell subsets by multicolor flow cytometry in 10 cord blood samples and 105 healthy individuals (HIs) ranging from 6 to 84 years of age. We found that the Eomes+ population has a higher differentiation degree than the Eomes- population. T cells in the Eomes- subset show proportionally less T Overall, the KIR+NKG2A + Eomes- CD8+ T-cell population shares similar characteristics with the Eomes+ population, although with a lower degree of differentiation, lower senescence marker expression, and a proportional decrease with age. Thus, we suspect that KIR+NKG2A + Eomes-CD8+ T cells may represent a less differentiated stage of the NK-like CD8+ T-cell subset.

Sections du résumé

BACKGROUND
KIR+NKG2A + Eomes+ CD8+ T cells, which are preferentially found with a T
METHODS
We compare the distribution of the memory phenotypes and senescence-associated markers of two T-cell subsets by multicolor flow cytometry in 10 cord blood samples and 105 healthy individuals (HIs) ranging from 6 to 84 years of age.
RESULTS
We found that the Eomes+ population has a higher differentiation degree than the Eomes- population. T cells in the Eomes- subset show proportionally less T
CONCLUSION
Overall, the KIR+NKG2A + Eomes- CD8+ T-cell population shares similar characteristics with the Eomes+ population, although with a lower degree of differentiation, lower senescence marker expression, and a proportional decrease with age. Thus, we suspect that KIR+NKG2A + Eomes-CD8+ T cells may represent a less differentiated stage of the NK-like CD8+ T-cell subset.

Identifiants

pubmed: 32830898
doi: 10.1002/cyto.b.21945
doi:

Substances chimiques

EOMES protein, human 0
IFNG protein, human 0
KLRC1 protein, human 0
NK Cell Lectin-Like Receptor Subfamily C 0
Receptors, KIR3DL1 0
T-Box Domain Proteins 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

467-475

Informations de copyright

© 2020 International Clinical Cytometry Society.

Références

Abedin, S., Michel, J. J., Lemster, B., & Vallejo, A. N. (2005). Diversity of NKR expression in aging T cells and in T cells of the aged: The new frontier into the exploration of protective immunity in the elderly. Experimental Gerontology, 40(7), 537-548. https://doi.org/10.1016/j.exger.2005.04.012
Aggarwal, N., Swerdlow, S. H., TenEyck, S. P., Boyiadzis, M., & Felgar, R. E. (2016). Natural killer cell (NK) subsets and NK -like T -cell populations in acute myeloid leukemias and myelodysplastic syndromes. Cytometry. Part B, Clinical Cytometry, 90(4), 349-357. https://doi.org/10.1002/cyto.b.21349
Arosa, F. A. (2017). Editorial: On the origin and function of human NK-like CD8+ T cells: Charting new territories. Frontiers in Immunology, 8, 1588. https://doi.org/10.3389/fimmu.2017.01588
Bailey, S. R., & Maus, M. V. (2019). Gene editing for immune cell therapies. Nature Biotechnology, 3, 1425-1434. https://doi.org/10.1038/s41587-019-0137-8
Barbarin, A., Cayssials, E., Jacomet, F., Nunez, N. G., Basbous, S., Lefèvre, L., … Gombert, J. M. (2017). Phenotype of NK-like CD8(+) T cells with innate features in humans and their relevance in cancer diseases. Frontiers in Immunology, 8, 316. https://doi.org/10.3389/fimmu.2017.00316
Björkström, N. K., Béziat, V., Cichocki, F., Liu, L. L., Levine, J., Larsson, S., … Malmberg, K. J. (2012). CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells. Blood, 120(17), 3455-3465. https://doi.org/10.1182/blood-2012-03-416867
Chen, G., Lustig, A., & ping, W. N. (2013). T cell aging: A review of the transcriptional changes determined from genome-wide analysis. Frontiers in Immunology, 4, 121. https://doi.org/10.3389/fimmu.2013.00121
Chou, J. P., & Effros, R. B. (2013). T cell replicative senescence in human aging. Current Pharmaceutical Design, 19, 1680-1698. https://doi.org/10.2174/1381612811319090016
D'Arena, G., Vitale, C., Coscia, M., Festa, A., Di Minno, N. M. D., De Feo, V., … Fenoglio, D. (2017). Regulatory T cells and their prognostic relevance in hematologic malignancies. Journal of Immunology Research, 2017, 1832968. https://doi.org/10.1155/2017/1832968
Effros, R. B. (2004). Replicative senescence of CD8 T cells: Effect on human ageing. Experimental Gerontology, 39(4), 517-524.
Fang, F. Q., Fan, Q. S., Yang, Z. J., Peng, Y. B., Zhang, L., Mao, K. Z., … Ji, Y. H. (2009). Incidence of cytomegalovirus infection in Shanghai, China. Clinical and Vaccine Immunology, 16(11), 1700-1703. https://doi.org/10.1128/CVI.00385-08
Ferreira, L. M. R., Muller, Y. D., Bluestone, J. A., & Tang, Q. (2019). Next-generation regulatory T cell therapy. Nature Reviews Drug Discovery, 18(10), 749-769. https://doi.org/10.1038/s41573-019-0041-4
Fessler, J., Ficjan, A., Duftner, C., & Dejaco, C. (2013). The impact of aging on regulatory T-cells. Frontiers in Immunology, 4, 231. https://doi.org/10.3389/fimmu.2013.00231
Franceschi, C., Salvioli, S., Garagnani, P., de Eguileor, M., Monti, D., & Capri, M. (2017). Immunobiography and the heterogeneity of immune responses in the elderly: A focus on inflammaging and trained immunity. Frontiers in Immunology, 8, 982. https://doi.org/10.3389/fimmu.2017.00982
Garcia-Prat, M., Álvarez-Sierra, D., Aguiló-Cucurull, A., Salgado-Perandrés, S., Briongos-Sebastian, S., Franco-Jarava, C., … Martínez-Gallo, M. (2019). Extended immunophenotyping reference values in a healthy pediatric population. Cytometry Part B, Clinical Cytometry, 96(3), 223-233. https://doi.org/10.1002/cyto.b.21728
Griffin, P., Michel, J. J., Huysman, K., Logar, A. J., & de Vallejo, A. N. (2012). Integration of immunity with physical and cognitive function in definitions of successful aging. Aging and Disease, 3(1), 34-50.
Hill, A. J., Zhang, C., Kusakabe, M., Gowing, K., Wang, X., Brinkman, R. R., Craig, J. W. (2020). Occurrence of T-cell and NK -cell subsets with less well-recognized phenotypes in peripheral blood submitted for routine flow cytometry analysis. Cytometry Part B, Clinical Cytometry, https://doi.org/10.1002/cyto.b.21876
Jacomet, F., Cayssials, E., Basbous, S., Levescot, A., Piccirilli, N., Desmier, D., … Gombert, J. M. (2015). Evidence for eomesodermin-expressing innate-like CD8 + KIR/NKG2A + T cells in human adults and cord blood samples. European Journal of Immunology, 45, 1926-1933. https://doi.org/10.1002/eji.201545539
Jameson, S. C., & Masopust, D. (2018). Understanding subset diversity in T cell memory. Immunity, 48(2), 214-226. https://doi.org/10.1016/j.immuni.2018.02.010
Kallemeijn, M. J., Boots, A. M. H., Van Der Klift, M. Y., Brouwer, E., Abdulahad, W. H., Verhaar, J. A. N., … Langerak, A. W. (2017). Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cells. Scientific Reports, 7(1), 5509. https://doi.org/10.1038/s41598-017-05849-1
Kasakovski, D., Xu, L., & Li, Y. (2018). T cell senescence and CAR-T cell exhaustion in hematological malignancies. Journal of Hematology & Oncology, 11, 91. https://doi.org/10.1186/s13045-018-0629-x
Klenerman, P. (2018). The (gradual) rise of memory inflation. Immunological Reviews, 283(1), 99-112. https://doi.org/10.1111/imr.12653
Kurioka, A., Klenerman, P., & Willberg, C. B. (2018). Innate-like CD8+ T-cells and NK cells: converging functions and phenotypes. Immunology, 154(4), 547-556. https://doi.org/10.1111/imm.12925
Lemster, B. H., Michel, J. J., Montag, D. T., Paat, J. J., Studenski, S. A., Newman, A. B., & Vallejo, A. N. (2008). Induction of CD56 and TCR-independent activation of T cells with aging. Journal of Immunology, 180(3), 1979-1990. https://doi.org/10.4049/jimmunol.180.3.1979
Li, M., Yao, D., Zeng, X., Kasakovski, D., Zhang, Y., Chen, S., … Xu, L. (2019). Age related human T cell subset evolution and senescence. Immunity & Ageing, 16, 24. https://doi.org/10.1186/s12979-019-0165-8
Li, Z., Song, W., Rubinstein, M., & Liu, D. (2018). Recent updates in cancer immunotherapy: A comprehensive review and perspective of the 2018 China cancer immunotherapy workshop in Beijing. Journal of Hematology & Oncology, 11(1), 142. https://doi.org/10.1186/s13045-018-0684-3
Luisa Pita-López, M., Pera, A., & Solana, R. (2016). Adaptive memory of human NK-like CD8+ T-cells to aging, and viral and tumor antigens. Frontiers in Immunology, 7. https://doi.org/10.3389/fimmu.2016.00616
Michel, J. J., Griffin, P., & Vallejo, A. N. (2016). Functionally diverse NK-like T cells are effectors and predictors of successful aging. Frontiers in Immunology, 7, 530. https://doi.org/10.3389/fimmu.2016.00530
Mojumdar, K., Vajpayee, M., Chauhan, N. K., Singh, A., Singh, R., & Kurapati, S. (2012). Altered T cell differentiation associated with loss of CD27 and CD28 in HIV infected indian individuals. Cytometry Part B, Clinical Cytometry, 82(1), 43-53.
Moro-García, M. A., Alonso-Arias, R., & López-Larrea, C. (2013). When aging reaches CD4+ T-cells: Phenotypic and functional changes. Frontiers in Immunology, 4, 107. https://doi.org/10.3389/fimmu.2013.00107
Moss, P., & Khan, N. (2004). CD8+ T-cell immunity to cytomegalovirus. Human Immunology, 65(5), 456-464. https://doi.org/10.1016/j.humimm.2004.02.014
Mou, D., Espinosa, J., Lo, D. J., & Kirk, A. D. (2014). CD28 negative T cells: Is their loss our gain? American Journal of Transplantation, 14(11), 2460-2466. https://doi.org/10.1111/ajt.12937
Pita-López, M. L., Pera, A., & Solana, R. (2016). Adaptive memory of human NK-like CD8+ T-cells to aging, and viral and tumor antigens. Front Immunol, 7(616), 1-8. https://doi.org/10.3389/fimmu.2016.00616
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., … Tian, D. (2020). Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clinical Infectious Diseases. http://dx.doi.org/10.2139/ssrn.3541136.
Sagebiel, A. F., Steinert, F., Lunemann, S., Körner, C., Schreurs, R. R. C. E., Altfeld, M., … Bunders, M. J. (2019). Tissue-resident Eomes + NK cells are the major innate lymphoid cell population in human infant intestine. Nature Communications, 10(1), 975. https://doi.org/10.1038/s41467-018-08267-7
Satija, R., & Shalek, A. K. (2014). Heterogeneity in immune responses: From populations to single cells. Trends in Immunology, 35(5), 219-229. https://doi.org/10.1016/j.it.2014.03.004
Shimizu, K., Sato, Y., Kawamura, M., Nakazato, H., Watanabe, T., Ohara, O., & Fujii, S. I. (2019). Eomes transcription factor is required for the development and differentiation of invariant NKT cells. Communications Biology, 2, 1-13. https://doi.org/10.1038/s42003-019-0389-3
Spurgeon, B. E. J., & Naseem, K. M. (2020). Platelet flow cytometry: Instrument setup, controls, and panel performance. Cytometry. Part B, Clinical Cytometry, 98(1), 19-27. https://doi.org/10.1002/cyto.b.217742019
Strickland, F. M., Patel, D., Khanna, D., Somers, E., Robida, A. M., Pihalja, M., … Richardson, B. (2016). Characterisation of an epigenetically altered CD4 + CD28 + Kir + T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry. Lupus Science & Medicine, 3(1), e000147. https://doi.org/10.1136/lupus-2016-000147
Takata, H., Naruto, T., & Takiguchi, M. (2012). Functional heterogeneity of human effector CD8+T cells. Blood, 119(6), 1390-1398. https://doi.org/10.1182/blood-2011-03-343251
Tu, W., & Rao, S. (2016). Mechanisms underlying T cell immunosenescence: Aging and cytomegalovirus infection. Frontiers in Microbiology, 7, 2111. https://doi.org/10.3389/fmicb.2016.02111
van den Berg, S. P. H., Pardieck, I. N., Lanfermeijer, J., Sauce, D., Klenerman, P., van Baarle, D., & Arens, R. (2019). The hallmarks of CMV-specific CD8 T-cell differentiation. Medical Microbiology and Immunology, 208(3-4), 365-373. https://doi.org/10.1007/s00430-019-00608-7
Wang, X., Hu, Y., Liu, X., Yu, J., Xu, P., Wei, G., … Huang, H. (2019). Quantitative characterization of T-cell repertoire alteration in Chinese patients with B-cell acute lymphocyte leukemia after CAR-T therapy. Bone Marrow Transplant, 54, 2072-2080. https://doi.org/10.1038/s41409-019-0625-y
Wing, J. B., Tanaka, A., & Sakaguchi, S. (2019). Human FOXP3 + regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity, 50(2), 302-316. https://doi.org/10.1016/j.immuni.2019.01.020
Xu, L., Yao, D., Tan, J., He, Z., Yu, Z., Chen, J., … Li, Y. (2018). Memory T cells skew toward terminal differentiation in the CD8+ T cell population in patients with acute myeloid leukemia. Journal of Hematology & Oncology, 11(1), 93. https://doi.org/10.1186/s13045-018-0636-y
Xu, L., Zhang, Y., Luo, G., & Li, Y. (2015). The roles of stem cell memory T cells in hematological malignancies. Journal of Hematology & Oncology, 8, 113. https://doi.org/10.1186/s13045-015-0214-5
Xu, W., & Larbi, A. (2017). Markers of T cell senescence in humans. International Journal of Molecular Sciences, 18(8), E1742. https://doi.org/10.3390/ijms18081742
Yarde, D. N., Lorenzo-Arteaga, K., Corley, K. P., Cabrera, M., & Sarvetnick, N. E. (2014). CD28-CD8+T cells are significantly reduced and correlate with disease duration in juveniles with type 1 diabetes. Human Immunology, 75, 1069-1074. https://doi.org/10.1016/j.humimm.2014.09.007
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., … Tian, Z. (2020). Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cellular & Molecular Immunology, 17(5), 533-535. https://doi.org/10.1038/s41423-020-0402-2
Zhou, Y., Zhang, Z., Tian, J., & Xiong, S. (2020). Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus. Annals of Palliative Medicine, 9(2), 428-436. https://doi.org/10.21037/apm.2020.03.26

Auteurs

Dimitri Kasakovski (D)

Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China.

Xiangbo Zeng (X)

Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China.

Jing Lai (J)

Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China.

Zhi Yu (Z)

Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China.

Danlin Yao (D)

Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China.

Shaohua Chen (S)

Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China.

Xianfeng Zha (X)

Department of Clinical Laboratory, First Affiliated Hospital, Jinan University, Guangzhou, China.

Yangqiu Li (Y)

Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China.

Ling Xu (L)

Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China.
The Clinical Medicine Postdoctoral Research Station, Jinan University, Guangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH